πŸ‡ΊπŸ‡Έ FDA
Patent

US 7780966

Artificial invaplex

granted A61KA61K2039/543A61K2039/55544

Quick answer

US patent 7780966 (Artificial invaplex) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/543, A61K2039/55544, A61K38/00, A61K39/0283